Although successful machine perfusion procedures of the liver were first performed almost four decades ago, technical and logistical constraints have prevented general acceptance. Interest in the procedure has recently been renewed due to its potential to resuscitate marginal organs. This review describes experimental and clinical liver hypothermic machine perfusion studies and current developments.
Introduction
Following the publication of a landmark paper in 1967 by Belzer et al. [1] , kidney preservation by hypothermic machine perfusion has become an established clinical activity. The first successful clinical application of liver hypothermic machine perfusion was described in 1968 [2] . To date, however, preservation of the liver by hypothermic machine perfusion has not followed. With the introduction of cold storage, clinical focus shifted away from hypothermic machine perfusion, as cold storage was easier to use, cheaper and did not involve the logistical drawbacks of hypothermic machine perfusion. In addition, cold storage of liver grafts using University of Wisconsin solution allowed for significantly longer preservation periods compared with Euro-Collins, the preservation solution used previously [3] . Nevertheless, the potential of liver hypothermic machine perfusion to extend preservation periods compared with cold storage was well recognized. Hypothermic machine perfusion has continued to be used for kidney preservation, and there is currently renewed interest in liver perfusion preservation with respect to improving the quality of marginal donor organs. In this review, we focus on experimental studies as well as on recent clinical developments in order to examine whether liver hypothermic machine perfusion remains a worthwhile clinical activity.
Current status
To date, the gold standard for preservation of regular cadaveric organs is cold flush followed by static, cold storage using an appropriate organ preservation solution. As suggested by St. Peter et al. [4] , however, the potential for static cold storage preservation has presently reached its limit. In order to expand the donor pool, the procurement of organs from marginal donors, such as from nonheart-beating donors (NHBD), has become a necessity. Clinical studies comparing graft and patient survival of heart-beating and NHBD livers show clear differences in favor of heart-beating-donor (HBD) grafts [5] [6] [7] . Organs with ischemic damage need a more effective method of preservation and, equally, a means for viability assessment prior to transplantation. Unlike cold storage, hypothermic machine perfusion holds the potential of viability assessment [8] and allows for pharmacological intervention. In addition, hypothermic machine perfusion potentially reverses the effects of ischemic injury that occur during warm ischemia, whereas cold storage leads to sequential injury with the risk of rendering grafts unviable for transplantation [9] .
Studies of hypothermic machine perfusion preservation of kidney grafts showed more favorable results for hypothermic machine perfusion, in particular for NHBD kidneys [10] . A similar advantage is expected for perfusion preservation of livers with ischemic damage [11] [12] [13] . In organs subjected to warm ischemia, such as in NHBD livers, it is essential to restore cellular energy levels. Continuous perfusion via the portal vein supplies metabolic substrates, removes waste products and allows for pharmacological interventions. In addition, the delivery of oxygen to the organ during the preservation period has shown encouraging results. The ultimate goal of liver preservation by hypothermic machine perfusion is to improve the quality of donor livers available for transplantation in order to expand the donor pool. In anticipation of clinical application, several landmark experimental studies have been performed. An overview of these is provided below, together with an insight into more recent developments.
Single or dual perfusion
Compared with machine perfusion of kidneys, hypothermic machine perfusion of liver grafts is more complicated due to the dual continuous and pulsatile blood supply. Approximately 80% of liver vascularization originates from the portal vein, the remaining 20% from the hepatic artery. Although responsible for a relatively small part of total blood supply, the hepatic artery is accountable for the largest part of the oxygen supply to the liver and, as it also supplies blood to the biliary tract, is not to be neglected [14] . Nevertheless, various studies have shown that perfusion of the portal vein alone results in viable livers upon reperfusion. Seventy-two hour in-situ perfusion of porcine livers via the portal vein improved preservation of energy metabolism compared with simple cold storage for 48 h [15] . The solutions used were, respectively, University of Wisconsin solution supplemented with an oxygen carrier and University of Wisconsin solution alone. Kim et al. [16] compared the mitochondrial function of rat livers after 48 h cold storage or hypothermic machine perfusion via the portal vein. Tissue adenosine-5 0 -triphosphate was significantly depleted after 48 h of cold storage, whereas hypothermic machine perfusion resulted in stimulation of adenosine-5 0 -triphosphate production in liver tissue. It was concluded that liver energy-generating capabilities are significantly better preserved by hypothermic machine perfusion than by cold storage. To investigate the efficacy of different routes of perfusion, a study was performed in rats evaluating perfusion via the portal vein, hepatic veins (by retrograde perfusion) or hepatic artery. Twenty-four and 48 h of hypothermic machine perfusion were compared with 24 and 48 h of cold storage, confirming the superiority of hypothermic machine perfusion over cold storage for liver preservation. Retrograde perfusion via the hepatic veins provided results similar to portal vein perfusion, whereas perfusion via the hepatic artery proved less beneficial [17] . The first successful clinical results of hypothermic machine perfusion of the liver, however, were achieved perfusing both the portal vein and the hepatic artery [2]. Belzer, who was the first to successfully pump canine kidneys in a pulsatile fashion, later focused his experimental work on hypothermic machine perfusion of the liver. In hypothermic machine perfusion studies of the porcine liver using cryoprecipitated plasma, the concept of dual perfusion was applied using continuous portal flow in combination with pulsatile arterial flow. Eight to ten hours of hypothermic machine perfusion resulted in 7-day survival of four out of five animals. When perfusion was extended to 24 h, only two of 12 animals survived beyond 12 h [18] . Two decades later, Belzer's group published the best results so far in hypothermic machine perfusion of the liver, reporting successful continuous hypothermic machine perfusion of canine livers for 72 h via the portal vein only, using University of Wisconsin-gluconate (UW-G) solution [19] . Seven of eight dogs survived for at least 7 days following orthotopic liver transplantation.
More recent studies using large-animal models described liver perfusion through both the portal vein and hepatic artery. In a porcine study comparing preservation by hypothermic machine perfusion and cold storage [20] , livers were preserved for 24 h followed by a 4-h phase of normothermic reperfusion to assess hepatocellular function and tissue viability. Perfusion was achieved using a prototype Liver Transporter (LTR, Organ Recovery Systems, Des Plaines, IL, USA) with constant perfusion pressures of 10-12 mmHg through the portal vein and 30 mmHg through the hepatic artery, resulting in perfusion flow rates of 0.3 ml/min/g liver in the portal vein and 0.1 ml/min/g liver in the hepatic artery. Compared with cold storage, livers preserved by hypothermic machine perfusion showed improved hepatocellular function and overall less parenchymal damage as indicated by improved oxygen consumption and lower alanine-aminotransferase levels, respectively. The improved results compared with cold storage preservation were attributed to better sinusoidal endothelial cell function and homogeneous sinusoidal perfusion.
Using the same prototype machine for hypothermic machine perfusion, Monbaliu et al. [21] performed a porcine transplant study. Four hours of cold storage (n ¼ 6) was compared with 4 h of hypothermic machine perfusion (n ¼ 8) and posttransplant recipient and graft survival, as well as liver damage and hepatocellular function, were assessed. Three-day survival was 83% (5/6) in the cold storage group and 25% (2/8) in the hypothermic machine perfusion group. Although hepatocellular damage appeared to be reduced by hypothermic machine perfusion, production of tumor necrosis factor-a and the degree of endothelial cell dysfunction after reperfusion were more markedly present in the hypothermic machine perfusion group. For that reason, the authors concluded that transplantation after liver hypothermic machine perfusion is feasible, but seems less advantageous over cold storage as compared with hypothermic machine perfusion of kidney grafts. Deprivation of oxygen during hypothermic machine perfusion might have played a major role in these poor results.
Another liver transplant study was performed by Guarrera et al. [22] in six miniature swine, comparing cold storage (n ¼ 3) with hypothermic machine perfusion (n ¼ 3), perfusing both the portal vein and hepatic artery in a flowcontrolled system. Posttransplant results of liver function were comparable between groups, with all animals surviving for 5 days. The same report describes a study of perfusing discarded human donor livers. Ten nontransplantable human livers were obtained and subjected to centrifugal hypothermic machine perfusion of both the portal vein and hepatic artery, according to a flowcontrolled system with target flow (0.7 ml/g/min) adjusted for graft weight. Portal vein and hepatic artery pressures ranged from 3 to 5 mmHg and 12 to 18 mmHg, respectively. From this study it was concluded that a safe and reliable method of centrifugal liver hypothermic machine perfusion had been developed. Using the same technique, hypothermic machine perfusion was used in a human liver transplant setting for the first time. Three donor livers were transplanted after hypothermic machine perfusion during 4-5.5 h and all grafts functioned immediately. Biopsies taken after reperfusion showed well preserved histology. Although this report does not provide for long-term survival data, all three recipients survived with a mean survival of 7 weeks [22, 23] .
Hypothermic machine perfusion supplemented with oxygenation was applied by Van der Plaats et al. [24 ] in their development of a new hypothermic machine perfusion system. Porcine livers were preserved for 24 h by cold storage using University of Wisconsin solution or 24 h of hypothermic machine perfusion using UW-G in the Groningen hypothermic liver perfusion pump. Continuous perfusion of the portal vein at 4 mmHg was applied simultaneously with pulsatile perfusion of the hepatic artery (30/20 mmHg at 60 beats per minute). Perfusion pressures were based on results from a previous study [25] from the same group performed in rats. They concluded that perfusion at 25% of normothermic liver circulation showed complete perfusion of the liver without induction of endothelial injury. Flow was approximately 350 ml/min and 80 ml/min, respectively, but decreased in the portal vein, possibly due to edema formation. The arterial oxygen tension was maintained at 100 kPa. In contrast to cold-stored livers, hypothermic machine perfusion-preserved livers showed complete and uniform perfusion. For further development of the concept of hypothermic dual perfusion of the liver, the system will have to be subjected to feasibility testing in a transplant setting.
Continuous or pulsatile perfusion
Techniques of liver perfusion have evolved over the years with the most successful results achieved in a transplantation study by Pienaar et al. [19] , who perfused canine livers in a pulsatile fashion through the portal vein only. Using an isolated perfusion model, Yamamoto et al. [15] succeeded in 72 h of hypothermic machine perfusion of porcine livers by continuous perfusion of the portal vein. Most recent attempts of simulating normal liver physiology in hypothermic machine perfusion systems led to the application of pulsatile flow for the hepatic artery and continuous or nonpulsatile flow for the portal vein [20,21,24 ,26] . Monbaliu et al. [21] performed a porcine liver transplantation study using pulsatile and nonpulsatile perfusion but results were poor, probably due to the lack of oxygen. Further studies are therefore necessary to show whether the liver will indeed benefit from a combination of pulsatile and nonpulsatile flow in an oxygenated environment, based on the rationale of mimicking normal liver physiology.
Effects of oxygenation
The exposure of liver grafts to ischemia and the shortage of energy substrates during static cold storage are detrimental to the liver, as hepatic metabolism, although reduced, is still active at hypothermia [27] . Therefore, oxygenated hypothermic machine perfusion was developed as a means of improving the quality of liver preservation [28] . Oxygenated preservation enables grafts to restore tissue homeostasis [29] and allows for maintenance of functional integrity of hepatocytes during ischemia. Mitchell et al. [30] have demonstrated that brief periods of temporary, substrate-free hypothermic oxygenation during long-term storage of rat livers significantly improved postischemic recovery of metabolism. Furthermore, it has long been recognized that continuous hypothermic perfusion of the liver, under optimal conditions of oxygenation, perfusate flow and substrate supply, can yield excellent preservation of the donor liver [19] . Poor results in hypothermic machine perfusion preservation studies using porcine livers were probably caused by the lack of oxygen [21, 22] .
Combined cold storage and hypothermic machine perfusion
The combination of cold storage and hypothermic machine perfusion for liver preservation was already shown to be effective in a canine transplant study almost two decades ago [31] . Six hours of cold storage followed by 42 h of hypothermic machine perfusion was considered an alternative preservation method with the aim of facilitating organ sharing between transplant units. Recently, enhanced shear stress induced by long-term continuous hypothermic perfusion has been reported to cause vascular injury and was therefore considered to be a serious drawback of hypothermic machine perfusion [32] . For that reason, the effect of shorter periods of hypothermic machine perfusion as an adjunct to cold storage was evaluated. Minor et al. [33 ] performed a rat liver preservation study comparing 18 h of cold storage with 18 h of hypothermic machine perfusion and 2 h of hypothermic machine perfusion followed by 16 h of cold storage of liver grafts subjected to 30 min of warm ischemia. From the results of enzyme release, excretory function and energy recovery upon reperfusion, it was concluded that hypothermic machine perfusion during 18 h significantly improved hepatic integrity compared with cold storage. Only 2 h of oxygenated perfusion preceding 16 h of cold storage seemed to be sufficient for recovery of parenchymal liver function and reduction of vascular activation to an extent comparable with long-term hypothermic machine perfusion. It was also suggested that combining short-term oxygenated hypothermic machine perfusion upon harvest with a subsequent period of cold storage is an alternative method of preserving predamaged grafts as it combines the advantages of both techniques. Another study from the same group [34 ] demonstrated that reversal of the deleterious effects of warm ischemia is possible even after a period of cold storage. In rat livers subjected to 30 min of warm ischemia, a subsequent 18-h period of cold storage was compared with 16 h of cold storage followed by 2 h of oxygenated hypothermic machine perfusion. Predamaged livers recovered after short-term hypothermic oxygenated perfusion, even without energetic support or nutritive stimulation. These results were confirmed by Dutkowski et al. [35 ] who showed that a liver metabolically depleted during cold storage or warm ischemia could be energy-recharged by short-term hypothermic machine perfusion [36 ] . In a HBD liver model, oxygenated perfusion after cold storage resulted in increased cellular energy, and upon normothermic reperfusion, less oxidative stress and decreased cell death compared with cold storage alone [35 ] . Liver transplantation after short-term hypother-mic machine perfusion of NHBD grafts resulted in a significant extension of animal survival [36 ]. Iwane et al. [37 ] investigated the effects of 30 min of normothermic perfusion prior to cold preservation of ischemically damaged rat livers. Oxygenated Krebs-Henseleit buffer with or without the antioxidant biliverdin was used as perfusate. It was concluded that normothermic, pre-cold storage perfusion improved the viability of grafts from NHBDs. The addition of biliverdin further increased the energy status of grafts.
Normothermic perfusion preservation
Hypothermic preservation is based on the principle of reducing the metabolic rate and hence decreasing oxygen demand. Preservation at near-body temperatures requires an adequate supply of oxygen to the tissues, which can only be delivered by continuous perfusion with the addition of an oxygen carrier to the perfusate.
Several advantages of warm perfusion of liver and kidney [38] have been described. The deleterious effects of hypothermia (primarily aggravation of endothelial cell injury and prolongation of ischemia) are avoided by subnormothermic (15-358C) [39] or normothermic oxygenated preservation. Normothermic, sanguinous perfusion can mimic the physiological state of the organ and is therefore assumed to be the least damaging method of preservation. Normothermic perfusion can potentially prolong preservation time compared with cold storage, and enables real-time viability assessment prior to transplantation. Experimental studies have shown advantages of this method over cold storage in maintaining viability of both HBD [40] and NHBD liver grafts [41] . One hour of warm ischemia followed by 24 h of cold storage in University of Wisconsin solution resulted in a completely nonviable organ. In contrast, 24 h of normothermic perfusion preservation produced a functioning liver, despite comparable ischemic injury. Using the same model for the preservation of porcine livers by isolated perfusion [42] , it was demonstrated that livers subjected to 60 min of warm ischemia had superior bile production and metabolic activity after 24 h of continued normothermic perfusion with oxygenated blood compared with 4 h of cold storage in University of Wisconsin solution followed by 20 h of normothermic perfusion preservation. Even a short period of cold ischemia proved to be deleterious to the function of ischemically damaged (NHBD) livers. These results were comparable to a transplant study addressing the preservation of warm, ischemically damaged livers described by Schö n et al. [43] . After a period of 60 min of warm ischemia, livers were preserved by 4 h of cold storage or normothermic perfusion. Unlike the normothermically preserved livers, the cold-preserved livers all suffered from primary nonfunction.
Normothermic perfusion of warm ischemically damaged livers throughout the preservation period using autologous blood not only replenishes cellular substrates but also ameliorates ischemic injury and provides for a clear assessment of liver function. This technique (combined with use of viability markers) could therefore permit the use of severely compromised organs. The only normothermic perfusion system currently under development for heart preservation, the Organ Care System (Transmedics Inc., Andover, MA, USA), is reported to be modified for future application of normothermic perfusion of the liver. Aside from the potential advantages of normothermic perfusion preservation over cold storage, this demanding technique will evidently lead to high costs and, due to its complexity, will place a significant burden on the workload of transplant personnel. For these reasons, it is uncertain whether this technique will really take off in clinical organ preservation.
Prevention of posttransplant biliary complications
The results of graft and patient survival and the complication rate in terms of ischemic type biliary lesions (ITBLs) vary according to the type of donor (heart-beating, nonheart-beating), the method of procurement, the preservation method and the sequence of revascularization [44] . First and foremost, a successful organ procurement and preservation procedure has to provide for a complete washout of the graft and, simultaneously, effective preservation of the biliary tree. It is well known that ITBLs lead to considerable morbidity following orthotopic liver transplantation [45] .
From experimental studies it was suggested that a proper initial washout procedure during organ procurement should be performed using high-perfusion pressure perfusion [46] and back-table arterial pressure perfusion [47] . Protection against biliary strictures was assumed to be dependent on the aortic flush solution's viscosity, rather than the cold ischemic time [48] . A clinical study comparing preservation using histidine-tryptophanketoglutarate (HTK) vs. University of Wisconsin solution showed no difference between groups in terms of ITBL (18.8% vs. 16 .0%, respectively) [45] . It was suggested that low viscosity by itself does not guarantee reliable perfusion of the small arteries of a liver graft and that pressure perfusion might be beneficial even when using a low viscosity solution such as HTK.
Recent developments
After an interval of almost four decades, clinical application of the technique of liver preservation by perfusion now appears to be in sight as both new hypothermic machine perfusion systems and perfusion solutions are currently under development.
Machine perfusion systems
Due to high costs, logistical and technical complexity, as well as the need for trained personnel, hypothermic machine perfusion up to now has not gained widespread acceptance. It has, however, been suggested that if a hypothermic machine perfusion system could be applied to the donor liver graft only for a limited time during the preparation of the recipient, the procedure would be easier to manage in the clinical setting [35 ] . In addition, if a readily transportable hypothermic machine perfusion system could be applied without the high costs and the complicated technology associated with hypothermic machine perfusion systems used previously, widespread acceptance of liver preservation by perfusion would stand an even better chance. To our knowledge, three systems are currently under development, all of which are transportable hypothermic machine perfusion units. Two systems have already been mentioned: the prototype Liver Transporter (Organ Recovery Systems) [20, 21] and the Groningen hypothermic liver perfusion pump [24 ] . The third machine perfusion system currently under development is a disposable device named the Airdrive (Doorzand Medical Innovations, Amsterdam, The Netherlands). To date, it is the only system that enables oxygenated perfusion preservation of both kidney and liver grafts [26] . Whereas the kidney is perfused in a pulsatile fashion, perfusion of the liver is established by nonpulsatile flow through the portal vein and simultaneous pulsatile flow through the hepatic artery. The Airdrive is now being assessed in a final series of preclinical testing.
Machine perfusion solutions
Hypothermic machine perfusion of the liver was accomplished in the 1960s using perfusates based on autologous blood [2] or cryoprecipitated plasma [49, 50] . Subsequently, acellular perfusion solutions were used, such as saline [51] and lactated Ringer's solution [52] . In the past decade, the most effective perfusion solution for liver preservation by hypothermic machine perfusion has been UW-G [19] . Recently, liver perfusion studies have been described using (modified) HTK [33 ,34 ] , oxygenated Krebs-Henseleit solution [37 ] , modified University of Wisconsin solution [12, 13, 32, 35 ] and Celsior-Hydroxyethyl starch [17] . Most recently, studies reported the use of Vasosol (Waters Medical Systems, Rochester, MN, USA) [22] and Polysol (Doorzand Medical Innovations, Amsterdam, The Netherlands) [53,54 ,55] . Vasosol is a UW-G-based solution with additional compounds in order to enhance its vasodilatory and antioxidant capacity [56] . The Polysol perfusion preservation solution was originally developed for application in the Airdrive system and was shown to improve liver preservation quality in rat and porcine hypothermic machine perfusion preservation studies of HBD [53, 54 ] as well as NHBD liver grafts [55] . As Polysol is a colloid-based solution with low viscosity, it appears to meet the suggested requirements [57] for optimal perfusion preservation, as the low viscosity allows for an effective washout and the colloid ensures prevention of edema formation and ITBL [48] .
Conclusion
Machine perfusion preservation of liver grafts is being increasingly reconsidered, as experimental studies have shown a benefit of oxygenated hypothermic machine perfusion in liver preservation, particularly in livers retrieved from marginal donors. Both hypothermic and normothermic perfusion preservation provide a complete and uniform washout and can restore the energy status of liver grafts. The current development of easier-touse hypothermic machine perfusion systems for liver preservation and new perfusion solutions exemplifies the renewed interest in liver preservation by hypothermic machine perfusion. After an intermission of approximately 40 years, clinical application of this promising technique for the preservation of livers now appears to be in sight.
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